Longitude Capital Partners V, LLC - 13 May 2025 SCHEDULE 13G Report for CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share (CTMX)

Filing Manager: Longitude Capital Partners V, LLC
Reporting Manager: Longitude Capital Partners V, LLC
Security: CytomX Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol: CTMX
Shares outstanding: 158M shares
Disclosed Ownership: 11.5M shares
Ownership: 7.3%
Form type: SCHEDULE 13G
Filing time: 20 May 2025, 21:00:40 UTC
Date of event: 13 May 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Longitude Capital Partners V, LLC	7.3%	11.5M	11.5M	/s/ Cristiana Blauth Oliveira	Cristiana Blauth Oliveira, Authorized Signatory
Longitude Venture Partners V, L.P.	7.3%	11.5M	11.5M	/s/ Cristiana Blauth Oliveira	Cristiana Blauth Oliveira, Authorized Signatory
Patrick G. Enright	7.3%	11.5M	11.5M	/s/ Cristiana Blauth Oliveira	Cristiana Blauth Oliveira, as attorney-in-fact for Patrick G. Enright
Juliet Tammenoms Bakker	7.3%	11.5M	11.5M	/s/ Cristiana Blauth Oliveira	Cristiana Blauth Oliveira, as attorney-in-fact for Juliet Tammenoms Bakker